What is Favipiravir? FDA Approves COVID-19 Prevention Study in US Nursing Homes

Armand Balboni, MD, PhD, JD, CEO of Appili Therapeutics, discusses progress toward FDA authorization and/or approval of favipiravir for COVID-19.